⟳ 3D Preview
🔒Sequence protected. Public page contains rendered media only; no sequence or raw aptamer PDB is supplied.
APTFAB catalogue item
Anti-CRP Aptamer
APT-CRP-001
Research Use Commercial Licence Available Experimentally Verified
A DNA aptamer developed against C-reactive protein (CRP) for biosensing, diagnostics, and inflammation-related research applications.
Price: Request quotation
Datasheet unavailable
Target Details
- Target Name
- C-Reactive Protein
- Scientific Name
- C-reactive protein
- Target Type
- Protein
- Organism
- Human
- UniProt ID
- P02741
- PDB ID
- 1B09
- Molecular Weight
- ~115 kDa
Aptamer Characteristics
- Aptamer Type
- DNA
- Length
- 40 nt
- Binding Format
- Single binder
- Sequence
- Not publicly disclosed
- Intended Use
- Research Use, Commercial Licensing
Chemical Modification
- 5′ amine
- 3′ biotin
- Custom modification available
Verification & Validation
- Methods
- SPR, Electrochemical
- Validation Level
- Experimentally Verified
- Sample Matrix
- PBS; serum
- Affinity
- Available upon request
Applications
The Anti-CRP Aptamer is designed for CRP-related research, biosensor development, and diagnostic proof-of-concept applications.
- High specificity positioning for CRP
- Suitable for biosensor immobilisation
- Supports custom end modifications
- Research or commercial enquiry supported
This aptamer is positioned for the following research and development applications:
DiagnosticsBiosensor
Additional platform-specific validation may be required before diagnostic, therapeutic, or regulated use.
Research use: Available for research projects, assay development, and proof-of-concept studies.
Commercial use: Commercial licensing and platform integration may be discussed through enquiry.
Sequence access: The proprietary nucleotide sequence is not displayed or sent to the public browser.